68 related articles for article (PubMed ID: 25853648)
1. Analysis of Cell-Surface Receptor Dynamics through Covalent Labeling by Catalyst-Tethered Antibody.
Hayashi T; Yasueda Y; Tamura T; Takaoka Y; Hamachi I
J Am Chem Soc; 2015 Apr; 137(16):5372-80. PubMed ID: 25853648
[TBL] [Abstract][Full Text] [Related]
2. Semisynthetic lectin-4-dimethylaminopyridine conjugates for labeling and profiling glycoproteins on live cell surfaces.
Hayashi T; Sun Y; Tamura T; Kuwata K; Song Z; Takaoka Y; Hamachi I
J Am Chem Soc; 2013 Aug; 135(33):12252-8. PubMed ID: 23889132
[TBL] [Abstract][Full Text] [Related]
3. Engineering and characterization of a bispecific HER2 x EGFR-binding affibody molecule.
Friedman M; Lindström S; Ekerljung L; Andersson-Svahn H; Carlsson J; Brismar H; Gedda L; Frejd FY; Ståhl S
Biotechnol Appl Biochem; 2009 Aug; 54(2):121-31. PubMed ID: 19492986
[TBL] [Abstract][Full Text] [Related]
4. Targeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles.
Owen SC; Patel N; Logie J; Pan G; Persson H; Moffat J; Sidhu SS; Shoichet MS
J Control Release; 2013 Dec; 172(2):395-404. PubMed ID: 23880472
[TBL] [Abstract][Full Text] [Related]
5. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
6. Domain-level antibody epitope mapping through yeast surface display of epidermal growth factor receptor fragments.
Cochran JR; Kim YS; Olsen MJ; Bhandari R; Wittrup KD
J Immunol Methods; 2004 Apr; 287(1-2):147-58. PubMed ID: 15099763
[TBL] [Abstract][Full Text] [Related]
7. Chemical cell-surface receptor engineering using affinity-guided, multivalent organocatalysts.
Wang H; Koshi Y; Minato D; Nonaka H; Kiyonaka S; Mori Y; Tsukiji S; Hamachi I
J Am Chem Soc; 2011 Aug; 133(31):12220-8. PubMed ID: 21761940
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
9. Traceless affinity labeling of endogenous proteins for functional analysis in living cells.
Hayashi T; Hamachi I
Acc Chem Res; 2012 Sep; 45(9):1460-9. PubMed ID: 22680975
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor-negative and human epidermal growth factor receptor 2-negative breast cancer tissue have the highest Ki-67 labeling index and EGFR expression: gene amplification does not contribute to EGFR expression.
Umemura S; Takekoshi S; Suzuki Y; Saitoh Y; Tokuda Y; Osamura RY
Oncol Rep; 2005 Aug; 14(2):337-43. PubMed ID: 16012712
[TBL] [Abstract][Full Text] [Related]
11. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.
Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS
Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319
[TBL] [Abstract][Full Text] [Related]
12. Labeling proteins by affinity-guided DMAP chemistry.
Tamura T; Hamachi I
Methods Mol Biol; 2015; 1266():229-42. PubMed ID: 25560079
[TBL] [Abstract][Full Text] [Related]
13. Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies.
Mazor O; Hillairet de Boisferon M; Lombet A; Gruaz-Guyon A; Gayer B; Skrzydelsky D; Kohen F; Forgez P; Scherz A; Rostene W; Salomon Y
Anal Biochem; 2002 Feb; 301(1):75-81. PubMed ID: 11811969
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation.
Ingargiola M; Dittfeld C; Runge R; Zenker M; Heldt JM; Steinbach J; Cordes N; Baumann M; Kotzerke J; Kunz-Schughart LA
Cytometry A; 2012 Oct; 81(10):865-73. PubMed ID: 22930585
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Characterization, and Selective Delivery of DARPin-Gold Nanoparticle Conjugates to Cancer Cells.
Deyev S; Proshkina G; Ryabova A; Tavanti F; Menziani MC; Eidelshtein G; Avishai G; Kotlyar A
Bioconjug Chem; 2017 Oct; 28(10):2569-2574. PubMed ID: 28806065
[TBL] [Abstract][Full Text] [Related]
16. Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: quantitative analysis of HER2 overexpression effects.
Hendriks BS; Opresko LK; Wiley HS; Lauffenburger D
Cancer Res; 2003 Mar; 63(5):1130-7. PubMed ID: 12615732
[TBL] [Abstract][Full Text] [Related]
17. A novel proximity assay for the detection of proteins and protein complexes: quantitation of HER1 and HER2 total protein expression and homodimerization in formalin-fixed, paraffin-embedded cell lines and breast cancer tissue.
Shi Y; Huang W; Tan Y; Jin X; Dua R; Penuel E; Mukherjee A; Sperinde J; Pannu H; Chenna A; DeFazio-Eli L; Pidaparthi S; Badal Y; Wallweber G; Chen L; Williams S; Tahir H; Larson J; Goodman L; Whitcomb J; Petropoulos C; Winslow J
Diagn Mol Pathol; 2009 Mar; 18(1):11-21. PubMed ID: 19214113
[TBL] [Abstract][Full Text] [Related]
18. Epitope mapping of epidermal growth factor receptor (EGFR) monoclonal antibody and induction of growth-inhibitory polyclonal antibodies by vaccination with EGFR mimotope.
Navari M; Zare M; Javanmardi M; Asadi-Ghalehni M; Modjtahedi H; Rasaee MJ
Immunopharmacol Immunotoxicol; 2014 Oct; 36(5):309-15. PubMed ID: 25070131
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of four affibody-based near-infrared fluorescent probes for optical imaging of epidermal growth factor receptor positive tumors.
Qi S; Miao Z; Liu H; Xu Y; Feng Y; Cheng Z
Bioconjug Chem; 2012 Jun; 23(6):1149-56. PubMed ID: 22621238
[TBL] [Abstract][Full Text] [Related]
20. A new method for mapping discontinuous antibody epitopes to reveal structural features of proteins.
Mumey BM; Bailey BW; Kirkpatrick B; Jesaitis AJ; Angel T; Dratz EA
J Comput Biol; 2003; 10(3-4):555-67. PubMed ID: 12935344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
